» Articles » PMID: 38368488

Genome-wide Epistasis Analysis Reveals Gene-gene Interaction Network on an Intermediate Endophenotype P-tau/Aβ Ratio in ADNI Cohort

Overview
Journal Sci Rep
Specialty Science
Date 2024 Feb 17
PMID 38368488
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia in the elderly worldwide. The exact etiology of AD, particularly its genetic mechanisms, remains incompletely understood. Traditional genome-wide association studies (GWAS), which primarily focus on single-nucleotide polymorphisms (SNPs) with main effects, provide limited explanations for the "missing heritability" of AD, while there is growing evidence supporting the important role of epistasis. In this study, we performed a genome-wide SNP-SNP interaction detection using a linear regression model and employed multiple GPUs for parallel computing, significantly enhancing the speed of whole-genome analysis. The cerebrospinal fluid (CSF) phosphorylated tau (P-tau)/amyloid-[Formula: see text] (A[Formula: see text]) ratio was used as a quantitative trait (QT) to enhance statistical power. Age, gender, and clinical diagnosis were included as covariates to control for potential non-genetic factors influencing AD. We identified 961 pairs of statistically significant SNP-SNP interactions, explaining a high-level variance of P-tau/A[Formula: see text] level, all of which exhibited marginal main effects. Additionally, we replicated 432 previously reported AD-related genes and found 11 gene-gene interaction pairs overlapping with the protein-protein interaction (PPI) network. Our findings may contribute to partially explain the "missing heritability" of AD. The identified subnetwork may be associated with synaptic dysfunction, Wnt signaling pathway, oligodendrocytes, inflammation, hippocampus, and neuronal cells.

Citing Articles

Scrutinizing neurodegenerative diseases: decoding the complex genetic architectures through a multi-omics lens.

Cocos R, Popescu B Hum Genomics. 2024; 18(1):141.

PMID: 39736681 PMC: 11687004. DOI: 10.1186/s40246-024-00704-7.


Biofluid biomarkers for Alzheimer's disease: past, present, and future.

An C, Cai H, Ren Z, Fu X, Quan S, Jia L Med Rev (2021). 2024; 4(6):467-491.

PMID: 39664082 PMC: 11629312. DOI: 10.1515/mr-2023-0071.

References
1.
Huang Z, Zhao J, Wang W, Zhou J, Zhang J . Depletion of LncRNA NEAT1 Rescues Mitochondrial Dysfunction Through NEDD4L-Dependent PINK1 Degradation in Animal Models of Alzheimer's Disease. Front Cell Neurosci. 2020; 14:28. PMC: 7043103. DOI: 10.3389/fncel.2020.00028. View

2.
Cordell H . Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet. 2002; 11(20):2463-8. DOI: 10.1093/hmg/11.20.2463. View

3.
Magno L, Lessard C, Martins M, Lang V, Cruz P, Asi Y . Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. Alzheimers Res Ther. 2019; 11(1):16. PMC: 6359863. DOI: 10.1186/s13195-019-0469-0. View

4.
Inestrosa N, Montecinos-Oliva C, Fuenzalida M . Wnt signaling: role in Alzheimer disease and schizophrenia. J Neuroimmune Pharmacol. 2012; 7(4):788-807. DOI: 10.1007/s11481-012-9417-5. View

5.
Qu J, Xiong X, Hujie G, Ren J, Yan L, Ma L . MicroRNA-132-3p alleviates neuron apoptosis and impairments of learning and memory abilities in Alzheimer's disease by downregulation of HNRNPU stabilized BACE1. Cell Cycle. 2021; 20(21):2309-2320. PMC: 8794521. DOI: 10.1080/15384101.2021.1982507. View